DETROIT, Michigan, July 21, 2021 (LifeSiteNews) — Kamala Harris last week invoked Jesus Christ’s commandment to “love thy neighbor” in an attempt to push as many Americans as possible to receive experimental COVID-19 shots.
“I do believe that the act of getting vaccinated is the very essence of what the Bible tells us when it says ‘Love thy neighbor,’” Harris said during remarks at a vaccine mobilization event in Detroit, Michigan.
“But what we know it means when we talk about love thy neighbor, is that yes, it may be the person next door, and it may be the man on the side of the road, and it may be a perfect stranger,” Harris continued. “And in the face of that stranger, you see a friend. That’s what this is about. And so by getting vaccinated, you are loving your neighbor.”
Harris repeated the “love thy neighbor” refrain during other vaccine promotion stops, and during remarks she made at the White House, which she posted to her Twitter page with the message, “Getting vaccinated embodies the spirit of ‘Love thy neighbor.’”
During her speech Harris failed to mention the growing number of safety concerns related to the experimental jabs, despite several of those concerns being officially recognized by various U.S. Government bodies.
Data released earlier this month from the Centers for Disease Control (CDC) VAERS system released reported 411,931 total adverse events in the United States following injections of experimental COVID-19 gene therapy vaccines, including 6,985 deaths and 34,065 serious injuries, between Dec. 14, 2020, and June 25, 2021. Such figures are based on voluntary reports to Vaccine Adverse Events Reporting System (VAERS), and the Harvard Pilgrim study found that under 1% of adverse effects from vaccines are reported to VAERS.
Last week The Food and Drug Administration (FDA) announced that it has added a label to Johnson & Johnson’s COVID-19 vaccine that warns of a risk of Guillain-Barré syndrome (GBS), a rare neurological disorder that can cause paralysis. The FDA’s GBS warning followed similar announcement by the European Medicines Agency (EMA) for AstraZeneca’s COVID-19 vaccine.
Story Continues At: dailynewsweek.com